Open access · US-GOV via ClinicalTrials.gov Clinical trial

Evaluation of the Efficacy of the UVMune 400 Fluid Sunscreen on the Face Versus Usual Photoprotection Routine on Visible and Measurable Signs of Aging

Authors not listed

Cosmetique Active International · 2024

Telomere attrition Human Randomized controlled trial

Abstract

This experimental, randomized study aims at evaluating the preventative effect of a Sun Protection Factor (SPF) 50+ sunscreen (Anthelios UVMUNE 400 Fluid SPF 50+) with high Ultraviolet A (UVA) protection on clinical signs of skin aging.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-10 MST

Cite this

APA

Anonymous. (2024). Evaluation of the Efficacy of the UVMune 400 Fluid Sunscreen on the Face Versus Usual Photoprotection Routine on Visible and Measurable Signs of Aging. <em>Cosmetique Active International</em>. https://clinicaltrials.gov/study/NCT06697288

Vancouver

Anonymous. Evaluation of the Efficacy of the UVMune 400 Fluid Sunscreen on the Face Versus Usual Photoprotection Routine on Visible and Measurable Signs of Aging. Cosmetique Active International. 2024.

BibTeX

@misc{anon2024Evalua, title = {Evaluation of the Efficacy of the UVMune 400 Fluid Sunscreen on the Face Versus Usual Photoprotection Routine on Visible and Measurable Signs of Aging}, author = {Anonymous}, journal = {Cosmetique Active International}, year = {2024}, }